Elite Pharmaceuticals, Inc.
Elite Pharmaceuticals, Inc.（ELTP）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · ELTP · 截至 2026年6月9日
活动摘要
买入笔数
1
P-Purchase only
卖出笔数
5
近12个月
买卖比
0.20
Buy/Sell (by trades)
整体情绪
Elite Pharmaceuticals, Inc.内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月9日
ELTP 季度内部人买卖趋势
ELTP 内幕交易卖出 · ELTP 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 9, 2026
活跃内部人
近12个月交易最活跃 · ELTP CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
ELTP 高管卖出股份 · ELTP 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Aug 25, 2025 | ELITE PHARMACEUTICALS INC /NV/ EVP Operations | Option | 2,500,000 | $75K | Form 4 |
| Aug 22, 2025 | ELITE PHARMACEUTICALS INC /NV/ EVP Operations | Sale | 500,000 | $262K | Form 4 |
| Jul 10, 2025 | Kirkov Kirko Chief Commercial Officer | Purchase | 16,366 | $10K | Form 4 |
| Oct 23, 2024 | Plassche Douglas SVP of Operations | Sale | 800,000 | $392K | Form 4 |
| Oct 24, 2024 | Plassche Douglas SVP of Operations | Sale | 333,932 | $170K | Form 4 |
| Mar 29, 2024 | Hakim Nasrat A CEO, President · Director | Award | 49,534,368 | — | Form 4 |
| Dec 29, 2023 | Hakim Nasrat A CEO, President · Director | Award | 2,223,147 | $153K | Form 4 |
| Nov 22, 2023 | WHITNELL JEFFREY A Director | Award | 547,657 | $20K | Form 4 |
| Nov 22, 2023 | Caskey Davis S Director | Award | 547,657 | $20K | Form 4 |
| Nov 22, 2023 | Dash Barry H Director | Award | 547,657 | $20K | Form 4 |
| Aug 28, 2022 | WHITNELL JEFFREY A Director | Award | 459,536 | $20K | Form 4 |
| Aug 28, 2022 | Caskey Davis S Director | Award | 459,536 | $20K | Form 4 |
| Aug 28, 2022 | Dash Barry H Director | Award | 459,536 | $20K | Form 4 |
| Jun 30, 2021 | WHITNELL JEFFREY A Director | Award | 295,570 | $20K | Form 4 |
| Jun 30, 2021 | Caskey Davis S Director | Award | 295,570 | $20K | Form 4 |
| Jun 30, 2021 | Dash Barry H Director | Award | 295,570 | $20K | Form 4 |
| Aug 24, 2020 | Hakim Nasrat A CEO & President · Director | Other | 158,017,321 | — | Form 4 |
| Aug 20, 2020 | Plassche Douglas SVP Operations | Award | 71,739 | $6K | Form 4 |
| Aug 20, 2020 | Caskey Davis S Director | Award | 516,781 | $45K | Form 4 |
| Aug 20, 2020 | WHITNELL JEFFREY A Director | Award | 516,781 | $45K | Form 4 |
| Aug 20, 2020 | Dash Barry H Director | Award | 516,781 | $45K | Form 4 |
| Jun 30, 2020 | Plassche Douglas SVP of Operations | Award | 574,597 | $50K | Form 4 |
| Feb 26, 2018 | Pfeifer Eugene M Director | Award | 161,374 | $20K | Form 4 |
| Feb 26, 2018 | Plassche Douglas SVP of Operations | Award | 201,717 | $25K | Form 4 |
| Feb 26, 2018 | Ward Carter Julian CFO, Sec., Treas. | Award | 242,060 | $30K | Form 4 |
ELITE PHARMACEUTICALS INC /NV/
EVP Operations
日期
Aug 25
股数
2,500,000
均价
$0.03
总金额
$75K
ELITE PHARMACEUTICALS INC /NV/
EVP Operations
日期
Aug 22
股数
500,000
均价
$0.52
总金额
$262K
Hakim Nasrat A
CEO, President · Director
日期
Dec 29
股数
2,223,147
均价
$0.07
总金额
$153K
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 ELTP 内幕交易
ELTP 内幕交易
Elite Pharmaceuticals, Inc.（ELTP）内幕交易数据来源于公司内部人（包括ELITE PHARMACEUTICALS INC /NV/ (EVP Operations), Kirkov Kirko (Chief Commercial Officer)）提交的SEC Form 4申报文件。过去12个月内，2位内部人向SEC提交了交易申报。ELTP内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Elite Pharmaceuticals, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
ELTP 内幕交易 · 5个问题Elite Pharmaceuticals, Inc.（ELTP）的内部人包括高管和董事，如ELITE PHARMACEUTICALS INC /NV/ (EVP Operations), Kirkov Kirko (Chief Commercial Officer)等。过去12个月内，2位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026